Navigation Links
Islet cells producing insulin cultivated in the lab

Now there is an answer, not to far, to the complexities of Type I diabetics and insulin injections. This is according to researchers at the University of Calgary whose bioengineering team announced //that they have developed a way of growing pancreatic cells in their laboratory.

In the words of Dr. Leo Behie, “This is a significant milestone on the path to effectively producing human tissue that may be used to treat Type 1 diabetes. There is a huge international push to find a human pancreatic cell source — a Holy Grail of sorts — that could be used for transplantation," he said. "Once it is found, our lab will be ready to grow these cells in a clinically acceptable manner."

Behie and colleagues reported they have cultured human cells that are believed to be good candidates for generating islet cells that can make insulin.

The successful growth and characterization of these functional islet cells in the lab led to the conclusion that they may be suitable for treating individuals with Type 1 diabetes. Happy at this feat Donna Lillie of the Canadian Diabetes Association said, "This is very encouraging news for people with Type 1 diabetes who look forward to a future without this serious condition."

Scientists at the University of Alberta in Edmonton were the first to successfully transplant islet cells into people with diabetes in 2000, freeing them from insulin injections.

The bottleneck with this study as of now is that it takes pancreas cells from as many as three donor cadavers to supply enough for one patient transplant. Still it is an excellent beginning and paves way for breakthrough treatment of Type I diabetes


'"/>




Page: 1

Related medicine news :

1. Islets May Lead to Diabetes Cure
2. Islet Cells May Lead to Diabetes CureChildren
3. MRI Can Monitor Transplanted Islets
4. Islet cell transplants for Type 1 Diabetes
5. Successful Islet Cell Transplant in Mice With Type 1 Diabetes
6. LCT Reports Major Step for Islet Transplantation in Diabetes Patient
7. Action of nerve cells
8. Therapy for stopping the spread of cancer cells
9. Hydroxyurea derivatives kill colon cancer cells
10. Creating brain cells from bone marrow
11. A Chinese herb kills cancer cells
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: